查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1546126

登革熱疫苗市場規模：疫苗類型、疫苗階段、通路、區域前景、競爭策略、細分市場預測（截至2033年）

Dengue Vaccines Market Size- By Type of Vaccine, By Vaccine Phase, By Distribution Channel- Regional outlook, Competitive Strategies and Segment Forecast to 2033
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 247 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計2033年全球登革熱疫苗市場規模將成長至18.1395億美元，預測期內複合年成長率為13.11%。

本報告調查了全球登革熱疫苗市場，並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場/地區/主要國家的詳細分析、競爭格局和主要企業概況的集合。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 促進因素、抑制因素、機會與挑戰分析
  • COVID-19 對市場的影響

第5章 市場變數與展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭狀況

  • 製造地、銷售區域、產品類型分佈
  • 併購、聯盟、產品發布、合作

第7章全球登革熱疫苗市場：依疫苗類型

  • 全球市場規模、佔有率和預測
  • 減毒活疫苗
  • 重組疫苗

第8章全球登革熱疫苗市場：依疫苗階段分類

  • 全球市場規模、佔有率和預測
  • 第一階段
  • 第二階段
  • 第三階段

第9章全球登革熱疫苗市場：依通路分類

  • 全球市場規模、佔有率和預測
  • 合成
  • 生物基

第10章全球登革熱疫苗市場預測

  • 市場規模/市場佔有率

第11章全球登革熱疫苗市場：按地區

  • 市場規模/市場佔有率趨勢/預測
  • 亞太地區
  • 歐洲
  • 中東/非洲
  • 北美洲
  • 拉丁美洲

第12章 公司簡介

  • Butantan Institute
  • GeneOne Life Science Inc.
  • GlaxoSmithKline Plc
  • Mylan NV
  • Medigen Vaccine Biologics Corporation
  • Merck and Co. Inc.
  • Nunn's Home Medical Equipment Company Ltd.
  • Panacea Biotec Limited
  • Sanofi Pasteur Limited
  • Serum Institute of India Pvt. Ltd.

第13章結論

第14章簡稱

第15章 參考鏈接

簡介目錄
Product Code: PHAR2411

Dengue Vaccines Market Introduction and Overview

According to SPER Market Research, 'Dengue Vaccines Market Size- By Type of Vaccine, By Vaccine Phase, By Distribution Channel - Regional outlook, Competitive Strategies and Segment Forecast to 2033' States that the Global Dengue Vaccines Market is estimated to reach USD 1813.95 million by 2033 with a CAGR of 13.11 %.

Dengue vaccines are designed to prevent dengue fever, a tropical illness spread by Aedes mosquitoes. The primary challenge in developing these vaccines lies in addressing the four different dengue virus serotypes (DENV-1, DENV-2, DENV-3, and DENV-4).

The focus on COVID-19 diverted resources, funding, and research efforts away from other infectious diseases, including dengue. This shift has slowed progress in the development and approval of new dengue vaccines.

Scope of the report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Type of Vaccine, By Vaccine Phase, By Distribution Channel

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Butantan Institute, GeneOne Life Science Inc., GlaxoSmithKline Plc, Mylan N.V., Medigen Vaccine Biologics Corporation, Merck and Co. Inc., Nunn's Home Medical Equipment Company Ltd., Panacea Biotec Limited, Sanofi Pasteur Limited, Serum Institute of India Pvt Ltd.

Global Dengue Vaccines Market Segmentation:

By Type of Vaccine: Based on the Type of Vaccine, Global Dengue Vaccines Market is segmented as; Live Attenuated Vaccines, Recombinant Vaccines.

By Vaccine Phase: Based on the Vaccine Phase, Global Dengue Vaccines Market is segmented as; Phase I, Phase II, Phase III.

By Distribution Channel: Based on the Distribution Channel, Global Dengue Vaccines Market is segmented as; Hospitals, Clinics, Retail Pharmacies.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Dengue Vaccines Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Dengue Vaccines Market Manufacturing Base Distribution, Sales Area, Product Type of Vaccine
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Dengue Vaccines Market

7. Global Dengue Vaccines Market, By Type of Vaccine (USD Million) 2020-2033

  • 7.1. Global Dengue Vaccines Market Size, Share and Forecast, By Type of Vaccine, 2020-2026
  • 7.2. Global Dengue Vaccines Market Size, Share and Forecast, By Type of Vaccine, 2027-2033
  • 7.3. Live Attenuated Vaccines
  • 7.4. Recombinant Vaccines

8. Global Dengue Vaccines Market, By Vaccine Phase (USD Million) 2020-2033

  • 8.1. Global Dengue Vaccines Market Size, Share and Forecast, By Vaccine Phase, 2020-2026
  • 8.2. Global Dengue Vaccines Market Size, Share and Forecast, By Vaccine Phase, 2027-2033
  • 8.3. Phase I
  • 8.4. Phase II
  • 8.5. Phase III

9. Global Dengue Vaccines Market, By Distribution Channel (USD Million) 2020-2033

  • 9.1. Global Dengue Vaccines Market Size, Share and Forecast, By Distribution Channel, 2020-2026
  • 9.2. Global Dengue Vaccines Market Size, Share and Forecast, By Distribution Channel, 2027-2033
  • 9.3. Synthetic
  • 9.4. Bio-Based

10. Global Dengue Vaccines Market Forecast, 2020-2033 (USD Million)

  • 10.1. Global Dengue Vaccines Market Size and Market Share

11. Global Dengue Vaccines Market, By Region, 2020-2033 (USD Million)

  • 11.1. Global Dengue Vaccines Market Size and Market Share By Region (2020-2026)
  • 11.2. Global Dengue Vaccines Market Size and Market Share By Region (2027-2033)
  • 11.3. Asia-Pacific
    • 11.3.1. Australia
    • 11.3.2. China
    • 11.3.3. India
    • 11.3.4. Japan
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4. Europe
    • 11.4.1. France
    • 11.4.2. Germany
    • 11.4.3. Italy
    • 11.4.4. Spain
    • 11.4.5. United Kingdom
    • 11.4.6. Rest of Europe
  • 11.5. Middle East and Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Qatar
    • 11.5.4. South Africa
    • 11.5.5. Egypt
    • 12.5.6. Morocco
    • 11.5.7. Nigeria
    • 11.5.8. Rest of Middle-East and Africa
  • 11.6. North America
    • 11.6.1. Canada
    • 11.6.2. Mexico
    • 11.6.3. United States
  • 11.7. Latin America
    • 11.7.1. Argentina
    • 11.7.2. Brazil
    • 11.7.3. Rest of Latin America

12. Company Profile

  • 12.1. Butantan Institute
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. GeneOne Life Science Inc.
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. GlaxoSmithKline Plc
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. Mylan N.V.
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. Medigen Vaccine Biologics Corporation
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. Merck and Co. Inc.
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Nunn's Home Medical Equipment Company Ltd.
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Panacea Biotec Limited
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. Sanofi Pasteur Limited
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. Serum Institute of India Pvt. Ltd.
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments

13. Conclusion

14. List of Abbreviations

15. Reference Links